Medicine pack check sheet

Source-linked reading points

• 50 mg and 200 mg are labelled strength per tablet; 40 mg/mL is the concentration after oral-suspension reconstitution; the 200 mg single-dose intravenous vial is another formulation identity. They are not the same unit and do not support self-conversion from tablets to millilitres, an infusion amount or substitution.
• For this one U.S. bottle, NDC 0049-3170-30, 30 tablets and 50 mg are combined clues. Package appearance, tablet colour, debossing or bottle count only help check a source; they cannot authenticate a product, establish interchangeability with another strength, or justify splitting, crushing or combining.
• The label flags many medicine and herbal interactions involving CYP2C19, CYP2C9 and CYP3A4 pathways. With an anticoagulant, antiseizure medicine, acid-suppressing medicine, immune-related medicine, herb or multiple medicines, have a pharmacist or prescribing team review every actual package item by item; brand names, a genetics report or a webpage cannot decide co-use.
• With visual changes, marked rash or sunlight-related skin changes, serious illness or uncertainty about the exact dosage form, use timely local medical support. Do not self-start, repeat, adjust, switch or abruptly stop antifungal treatment from this page; it only helps read product-identity and risk clues in the label.